Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study
- 11 January 2024
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (3) , 409-416
Abstract
Acute graft-versus-host disease (aGvHD) is a serious complication of allogeneic hematopoietic stem-cell transplantation with limited treatment options. The gut microbiome plays a critical role in aGvHD pathogenesis. Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic approach to restore gut microbial diversity. In this prospective pilot study, 21 patients with steroid-resistant or steroid-dependent lower gastrointestinal aGvHD received FMT in capsule form. At 28 days after the first FMT, the overall response rate was 52.4%, with 23.8% complete and 28.6% partial responses. However, sustained responses were infrequent, with only one patient remaining aGvHD-free long-term. FMT was generally well-tolerated. Microbiome analysis revealed dysbiosis in pre-FMT patient stool samples, with distinct microbial characteristics compared to donors. Following FMT, there was an increase in beneficial Clostridiales and a decrease in pathogenic Enterobacteriales. These findings highlight the potential of FMT as a treatment option for steroid-resistant aGvHD. Trial registration number NCT #03214289.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA282987)
- The study was also supported by the Dahlia Greidinger Anti Cancer Fund, the Gassner Fund for Medical Research, and an institutional grant from the Chaim Sheba Medical Center
This publication has 33 references indexed in Scilit:
- Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2015
- Oral, Capsulized, Frozen Fecal Microbiota Transplantation for RelapsingClostridium difficileInfectionJAMA, 2014
- Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised PatientsAmerican Journal of Gastroenterology, 2014
- Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practiceBone Marrow Transplantation, 2013
- Infliximab for steroid refractory or dependent gastrointestinal acute graft‐versus‐host disease in children after allogeneic hematopoietic stem cell transplantationPediatric Transplantation, 2012
- Diagnosis and management of acute graft‐versus‐host diseaseBritish Journal of Haematology, 2012
- Graft-versus-host diseaseThe Lancet, 2009
- Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARBApplied and Environmental Microbiology, 2006
- Role of Skin Biopsy to Confirm Suspected Acute Graft-vs-Host DiseaseArchives of Dermatology, 2006
- Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorBone Marrow Transplantation, 2003